Fatty acids and cardiovascular disease

Nutrition Reviews

Volumn 67, Issue 5, 2009, Pages 273-283

  Lecerf, Jean Michel ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Cardiovascular risk; Dairy fat; Saturated fatty acids; Unsaturated fatty acids

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MILK FAT; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; VEGETABLE OIL; CHOLESTEROL; EDIBLE OIL; LOW DENSITY LIPOPROTEIN; UNSATURATED FATTY ACID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DAIRY PRODUCT; FAT INTAKE; FATTY ACID METABOLISM; FOOD COMPOSITION; HEART PROTECTION; HUMAN; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; BLOOD; METABOLISM;

ANIMALIA;

CARDIOVASCULAR DISEASES; CHOLESTEROL; DAIRY PRODUCTS; DIETARY FATS; DIETARY FATS, UNSATURATED; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; HUMANS; LIPOPROTEINS, LDL; RISK FACTORS;

EID: 67650718128     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2009.00194.x     Document Type: Review

References (103)

1. Torrejon C, Jung UJ, Deckelbaum RJ. n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids. 2007;77:319-326.
2. Keys A. Coronary heart disease in seven countries. Circulation. 1970;41(Suppl 1):120-122.
3. Kagan A, Harris BR, Winkesstein W, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis. 1974;27:345-364.
4. Medalie JH, Kahn HA, Neufeld H, Risse E, Golbourt U. Five year myocardial infarction incidence II. Association of single variables to age and birth place. J Chronic Dis. 1973;26:329-349.
5. Kushi LH, Lew RA, Stare FJ, et al. Diet and 20 year mortality from coronary heart diseases. The Ireland Boston Diet Heart Study. N Engl J Med. 1985;312:811-818.
6. Esrey KL, Joseph L, Grover SA. Relationship between dietary intake and coronary heart disease mortality: Lipid Research Clinics Prevalence follow-up study. J Clin Epidemiol. 1996;49:211-216.
7. Hu FB, Manson JF, Willett W. Type of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001;20:5-19. (Pubitemid 32244959)
8. Kromhout D. On the waves of the Seven Countries Study. A public health perspective on cholesterol. Eur Heart J. 1999;20:796-802. (Pubitemid 29240250)
9. Hjermann I, Holme I, Velve KR, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet. 1981;12:1303-1310.
10. Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S. Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study. Eur J Clin Nutr. 2006;60:378-385.
11. Holme I, Haamein LL, Tonstad S, Hjermann I. Effect of dietary and antismoking advice on the myocardial infarction: a 16 year follow-up of the Oslo Diet and Antismoking Study after its close. Nutr Metab Cardiovasc Dis. 2006;16:330-338.
12. Hayes KC, Khosla P. Dietary fatty acid thresholds and cholesterolemia. FASEB J. 1992;6:2600-2607.
13. Kris-Etherton PH, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 1997;65(Suppl):S1628-S1644.
14. Berard AM, Dabadie H, Palos-Pinto A, Dumon MF, Darmon M. Reduction of dietary saturated fatty acids correlates with increased plasma lecithin cholesterol acyltransferase activity in humans. Eur J Clin Nutr. 2004;58:881-887.
15. Nicholls SJ, Lundman P, Harmer JA. Consumption of saturated fat impairs the anti-inflammatory properties of highdensity lipoproteins and endothelial function. Am Coll Cardiol. 2006;48:715-720.
16. Müller H, Lindman AS, Brantsaeter AL, Pedersen JI. The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. J Nutr. 2003;133:78-83.
17. Lecerf JM, Luc G, Marecaux N, et al. Une faible variation qualitative des apports en acides gras diminue le cholestérol LDL de sujets hyper-cholestérolémiques. Med Nutr. 2005;41:165-174.
18. Dreon DH, Fernstrom HA, Campos H,Williams PT, Krauss RM. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr. 1998;67:828-836.
19. Dreon DM, Fernstrom HA, Williams PT, Krauss RM. A verylow- fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr. 1999;69:411-418.
20. Williams PT, Krauss RM. Low-fat diets, lipoprotein subclasses, and heart disease risk. Am J Clin Nutr. 1999;70:949-950.
21. German JB, Dillard CJ. Saturated fats: what dietary intake? Am J Clin Nutr. 2006;80:550-559.
22. Bonamone A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med. 1988;318:1244-1248.
23. Dabadie H. Myristic acid: from physiological role to atherogenous effect. Sci Aliments. 2002;22:355-363.
24. Renaud S, Morazain R, Godsey F, et al. Nutrients, platelet function and composition in nine groups of French and British farmers. Atherosclerosis. 1986;60:37-48.
25. Tholstrup T, Miler GJ, Bysted A, Sandstrom B. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men. Am J Clin Nutr. 2003;77:1125-1132.
26. Hu FB, Stampfer MJ, Manson JE. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491-1499.
27. Lopez-Miranda J, Badimon L, Bonamone A, et al. Monounsaturated fat and cardiovascular risk. Nutr Rev. 2006; 64(Suppl 2):S2-S12.
28. Lands WE. Primary prevention in cardiovascular disease: moving out of the shadows of the truth about death. Nutr Metab Cardiovasc Dis. 2003;13:154-164.
29. Kris-Etherton PM, Hecker KD, Binkoski AE. Polyunsaturated fatty acids and cardiovascular health. Nutr Rev. 2004; 62:414-426.
30. Leng GC, Taylor GS, Lee AJ, Fowkes GR, Horrobin D. Essential fatty acids and cardiovascular disease: the Edinburgh artery study. Vasc Med. 1999;4:219-226.
31. Kark JD, Kaufmann AN, Binka F, Goldberger N, Berry EM. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr. 2003;77:769-802.
32. Blankenhorn DH, Johnson RL, Mack WJ, El Zein HA, Vailas I. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA. 1990;263:1646-1682.
33. Dwyer JH, Allayee H, Dwyer K, Fan J. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid and atherosclerosis. N Engl J Med. 2004;350:29-37.
34. Okuyama H, Fujii Y, Ikemoto A. N-6/n-3 ratio of dietary fatty acids rather than hypercholesterolemia as the major risk factor for atherosclerosis and coronary heart disease. J Health Sci. 2000;46:157-177.
35. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167:237-242.
36. Thies F, Garry JMC, Yagoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003; 361:477-485.
37. Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr. 2008;87(Suppl):S1991-S1996.
38. Dolocek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev Nutr Diet. 1991;66:205-216.
39. Ascherio A, Rimm EB, Giovannucci FL, Speigelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow-up study in the United States. Br Med J. 1996;313:84-90.
40. Hu FB, Stampfer MJ, Manson JE, et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890-897.
41. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H. Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation. 2003;107:1586-1591. (Pubitemid 36397325)
42. Djousse L, Pankow JS, Eckfeldt JH, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2001;74:612-619.
43. Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the national Heart, Lung and Blood Institute Family Heart Study. Am J Clin Nutr. 2003;77:819-825.
44. Oomen CM, Ocke MC, Feskens EJM, Kok FJ, Kromhout D. a-linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:457-463.
45. De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha linolenic acid rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-1459.
46. Singh RB, NiazMA, Sharma JP, Kumar R, Rastogi V, Hoshiri M. Randomized, double-blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther. 1997;11:485-491.
47. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo- Mediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind-trial. Lancet. 2002;360:1455-1461.
48. Baylin A, Narvaez R, Kraft P, Campos H. a linolenic acid, (6-desaturase gene polymorphism and the risk of non fatal myocardial infarction. Am J Clin Nutr. 2007;85:554-560.
49. Lecerf JM. Poisson, acides gras oméga 3 et risque cardiovasculaire: données épidémiologiques. Cah Nutr Diet. 2004;39: 143-150.
50. Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117-119.
51. Kromann N, Green M. Epidemiological studies in the Upernavik District, Greenland. Incidence of some chronic diseases, 1950-1974. Acta Med Scand. 1980;208:401-406.
52. Guallar E, Aro A, Jimenez J, et al. Omega-3 fatty acids in adipose tissues and risk of myocardial infarction: the Euramic study. Arterioscler Thromb Vasc Biol. 1999;19: 1111-1118.
53. Albert CM, Hennekens CH, O'Donnel CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-28.
54. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118.
55. Burr ML, Gilbert JF, Holliday RM, et al. Effects of changes in fat, fish, and fiber intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.
56. Ness AR, Hughes J, Elwood PC, Whitley E, Smith GD, Burr ML. The long-term effect of dietary advice inmen with coronary disease: follow-up of the diet and reinfarction trial (DART). Eur J Clin Nutr. 2002;56:512-518.
57. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
58. Marchiolo R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the GISSI-Prevenzione. Circulation. 2002;105:1897-1903.
59. White C. Suspected research fraud: difficulties of getting at the truth. BMJ. 2005;331:281-288.
60. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193-200.
61. De Caterina R, Liao J, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000;71(Suppl 1):S213-S223.
62. Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary alphalinolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr. 2007;85:385-391.
63. Chrysohodu C, Panagiatakos DB, Pitsavos C, et al. Long term fish consumption is associated with protection against arrythmia in healthy persons in a Mediterranean region - the ATTICA Study. Am J Clin Nutr. 2007;85:1385-1391.
64. Metcalf RG, James MJ, Gibson RA, et al. Effects of fish oil supplementation onmyocardial fatty acids in humans. Am J Clin Nutr. 2007;85:1222-1228.
65. Krebs JD, Browning LM, Mc Lean NK, et al. Additive benefits of long chain n-3 polyunsaturated fatty acids and weight-loss in the management of hyperinsulinemic women. Int J Obes. 2006;30:1535-1544.
66. Buettner R, Schölmerich J, Cornelius Bollheimer C. High fat diets: modelling the metabolic disorder of human obesity in rodents. Obesity. 2007;15:798-808.
67. Huber J, Löffler M, Bilban M, et al. Prevention of high fat diet-induced adipose tissue remodelling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes. 2007;31:104-113.
68. Katan MB. Alternatives to low-fat diets. Am J Clin Nutr. 2006;83:989-990.
69. Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004;80:1175-1184.
70. Lefevre M, Champagne CM, Tulley RT, Rood JC, Modt MM. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr. 2005;82:957-963.
71. Wood RJ. Effect of dietary carbohydrate restriction with and without weight loss on atherogenic dyslypidemia. Nutr Rev. 2006;6:539-545.
72. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83:1025-1031.
73. Howard BV, Van Horn JH, Manson JE, Stefanick S. Low fat dietary pattern and risk of cardiovascular disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655-666.
74. Howard BV. Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutr Metab Cardiovasc Dis. 2007;17:171-174.
75. Kuller LH, Simkin-Sil Verman LR, Wing RR, Meilahn EN, Ives DG. Women's healthy lifestyle project: a randomized clinical trial. Results at 54 months. Circulation. 2001;103:32-37.
76. Wildman RP, Schott LL, Brockwell S, Kuller LH, Sutton-Tyrell K,Wenger NK. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol. 2004;44:579-585.
77. Mann GV, Shaffer RD, Anderson RS, Sandstead HH. Cardiovascular disease in the Masaï. J Atheroscler Res. 1964;4:289-312.
78. Mann GV, Spoerry A, Gray M, Jarashow D. Atherosclerosis in the Masaï. Am J Epidemiol. 1972;95:26-37.
79. Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol. 1998;51:443-460.
80. Brown S, Ordovas JM, Campos H. Interaction between the apo CIII gene promotor polymorphisms, saturated fat intake and plasma lipoproteins. Atherosclerosis. 2003;170:307-313.
81. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992; 339:1523-1526.
82. Elwood PC, Pickering JE, Hugues J, Fehily AM, Ness AR. Milk drinking, ischemic heart disease and ischemic stroke II. Evidence fromcohort studies. Eur J Clin Nutr. 2004;58:718-724.
83. Elwood PC, Pickering JE, Fehily JE, Huyghes J, Ness AR. Milk drinking ischemic heart disease and ischemic stroke I. Evidence from the Caerphilly Cohort. Eur J Clin Nutr. 2004; 58:711-717.
84. Biong AS, Veierod MD, Ringstad J, Thelle DS, Pedersen JI. Intake of milk fat, reflected in adipose tissue fatty acids, and risk of myocardial infarction: a case control study. Eur J Clin Nutr. 2006;60:236-244.
85. Warensjo E, Jansson JH, Berglund L, et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control-study. Br J Nutr. 2004;91:635-642.
86. Gillman MW, Cupples LA, Millen BE, Ellison RC, Wolf AW. Inverse association of dietary fat with development of ischemic stroke in men. JAMA. 1997;278:2145-2150.
87. Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26:11-23.
88. He KA, Merchant A, Rimm EB, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ. 2003;327:777-782.
89. Gray AR. Serum fatty acids as biomarkers of fat intake predict serum cholesterol concentrations in a populationbased survey of New Zealand adolescents and adults. Am J Clin Nutr. 2006;83:887-894.
90. Nestel PJ, Chronopoulos A, Cehun M. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolemic subjects. Eur J Clin Nutr. 2005;59: 1059-1063.
91. Gueguen L. Interactions lipides-calcium alimentaires et biodisponibilité du calcium du fromage. Cah Nutr Diet. 1992;27:311-315.
92. Lecerf JM, Borgies B, Bal S, Cazaubiel M, Bard JM. Une eau riche en calcium peut-elle avoir un effet sur les lipides plasmatiques? 2ème Congrès de la Société Française de Nutrition 2005 - Clermont Ferrand.
93. Erholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 weeks intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000;54:286-297.
94. Idel C, Deuffel T, Jahreis G. Effects of fat-modified dairy products on blood lipids in humans in comparisons with other fats. Ann Nutr Metab. 2005;49:42-48.
95. St Onge MD, Farnworth ER, Jones PJ. Consumption of fermented and non-fermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr. 2000;71:674-681.
96. Kiebling G, Schneider J, Jahreis G. Long term consumption of fermented dairy products over 6 months increased HDL cholesterol. Eur J Clin Nutr. 2002;56:843-849.
97. Ferrieres J, Bingard V, Dallongeville J, et al. Consommation de produits laitiers et facteurs de risque cardiovasculaire dans l'étude MONICA. Cah Nutr Diet. 2006;41:33-36.
98. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity and the insulin resistance syndrome in young adults. The CARDIA study. JAMA. 2002;287:2081-2089.
99. Mennen LJ, Lafay L, Feskens EJM, Novak M, Lepinay P, Balkau B. Possible protective effect of bread and dairy product on the risk of the metabolic syndrome. Nutr Res. 2000;20:335-347.
100. Azadbakht L, Mirmiran P, Esmailzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005;82:523-530.
101. Suter PM. The effects of potassium, magnesium, calcium, and fiber on risk of stroke. Nutr Rev. 1999;57:84-88.
102. Barba G, Russo P. Dairy foods, dietary calcium and obesity: a short review of the evidence. Nutr Metab Cardiovasc Dis. 2006;16:445-451.
103. Reed DM, Mac Lean CJ, Hayashi T. Predictors of arterosclerosis in the Honolulu Heart Program. I. Biologic, dietary, and lifestyle characteristics. Am J Epidemiol. 1987;126:214-225.